title: [Thalidomide and thrombosis: three observations].
authors: J
authors: J
authors: Pouaha
authors: S
authors: S
authors: Martin
authors: P
authors: P
authors: Trechot
authors: F
authors: F
authors: Truchetet
authors: A
authors: A
authors: Barbaud
authors: J L
authors: JL
authors: Schmutz
mesh_terms: D000328:Adult; D000368:Aged; D001528:Behcet Syndrome / Q000188:drug therapy; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use; D013927:Thrombosis / Q000139:chemically induced*
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide